Look for:

Products

BAUSCH HEALTH COMPANIES INC.


ISIN:
CA0717341071
WKN:
071734107

2024/08/16 16:14:57
Price
5.7609 USD
Difference 0.36% (0.02)

General attributes

ISINCA0717341071
SymbolBHC
ExchangeNYSE
CurrencyUSD
SectorOther
Security typeStock
Market cap (m)1,920 EUR
BenchmarkS&P/TSX 60 INDEX

Market data

Bid (Bid size)5.76 USD (500)
Ask (Ask size)5.77 USD (700)
Open5.72 USD
High5.81 USD
Low5.66 USD
Close (prev. day)5.74 USD
VWAP5.750197 USD
Volume (pcs)73,550
Trading volume423,013.76
Number of trades645
Last size100

Futures and Options

Related Futures15
Related Options-

PDF Downloads

Company report: BAUSCH HEALTH COMPANIES INC.PDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research

Date Headline Download
2024/08/12 en Global Equity Ratings PDF Download
2024/07/24 en Global Equity Ratings PDF Download
2024/07/12 en Global Equity Ratings PDF Download
2024/06/21 en Global Equity Ratings PDF Download
2024/06/14 en Global Equity Ratings PDF Download


2024/08/16 16:14:57
Price
5.7609 USD
Difference 0.36% (0.02)

General attributes

ISINCA0717341071
SymbolBHC
ExchangeNYSE
CurrencyUSD
SectorOther
Security typeStock
Market cap (m)1,920 EUR
BenchmarkS&P/TSX 60 INDEX

Market data

Bid (Bid size)5.76 USD (500)
Ask (Ask size)5.77 USD (700)
Open5.72 USD
High5.81 USD
Low5.66 USD
Close (prev. day)5.74 USD
VWAP5.750197 USD
Volume (pcs)73,550
Trading volume423,013.76
Number of trades645
Last size100

Performance and Risk

6m1Y3Y
Perf (%)-32.39%-31.01%-79.17%
Perf (abs.)-2.75-2.58-21.82
Beta1.891.601.81
Volatility56.7149.1270.19
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)5.5160 USD (1,093,820)
Ø price 30 days | Ø volume 30 days (pcs.)6.4287 USD (5,169,502)
Ø price 100 days | Ø volume 100 days (pcs.)7.3136 USD (3,724,310)
Ø price 250 days | Ø volume 250 days (pcs.)7.7349 USD (2,976,066)
YTD High | date11.4600 USD (2024/04/03)
YTD Low | date3.9600 USD (2024/07/24)
52 Weeks High | date11.4600 USD (2024/04/03)
52 Weeks Low | date3.9600 USD (2024/07/24)

Arbitrage views

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Berlin2024/08/1608:085.158 EUR0.001
Duesseldorf2024/08/1608:105.152 EUR0.001
Frankfurt2024/08/1608:085.156 EUR0.001
Munich2024/08/1608:085.158 EUR0.001
NYSE2024/08/1616:145.7609 USD0.42645
SIX Swiss Exchange2019/06/2817:3524.11 CHF0.001
Stuttgart2024/08/1616:055.233 EUR0.005
Toronto Stock Exchange2024/08/1616:127.90 CAD0.17152
Tradegate2024/08/1612:265.302 EUR0.004

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=98103&ID_TYPE_IMAGE_LOGO=2

Contact Details

BAUSCH HEALTH COS. INC.
- -
2150 St. Elzéar Boulevard West - H7L 4A8 Laval
Telefon: +1-514-744-6792
Fax: +
E-mail: -

PDF Downloads

Company report: BAUSCH HEALTH COMPANIES INC.PDF Download

Company Profile

Bausch Health Cos., Inc. engages in the development, manufacture and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. It operates through the following segments: Salix, International, Solta Medical, Diversified Products, and Bausch + Lomb. The Salix segment consists of sales in the U.S. of GI products. Sales of the Xifaxan product line. The International segment comprises of sales, except for sales of Bausch + Lomb products and Solta aesthetic medical devices, outside the U.S and Puerto Rico of branded pharmaceutical products, branded generic pharmaceutical and OTC products. The Solta Medical segment refers to global sales of Solta Medical aesthetic medical devices. The Diversified Products segment covers sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes, generic products, ortho dermatologic, and dentistry products. The Bausch + Lomb segment are global sales of Bausch + Lomb vision care, surgical and ophthalmic pharmaceuticals products. The company was founded on March 29, 1994, and is headquartered in Laval, Canada.

Members of Management Board

Thomas AppioChairman of Managing Board
Tage RamakrishnaMember of Executive Committee
Cees HeimanMember of Executive Committee
Fernando ZarateMember of Executive Committee
Graham JacksonMember of Executive Committee
Jeff HartnessMember of Executive Committee
Kathleen FitzpatrickMember of Executive Committee
Mirza DautbegovicMember of Executive Committee
Seana CarsonMember of Executive Committee
Tom VadakethMember of Executive Committee

Board of directors

John PaulsonChairman of Supervisory Board
Amy WechslerMember of Supervisory Board
Richard MulliganMember of Supervisory Board
Brett IcahnMember of Supervisory Board
Christian GarciaMember of Supervisory Board
Frank LeeMember of Supervisory Board
Robert PowerMember of Supervisory Board
Sarah KavanaghMember of Supervisory Board
Steven MillerMember of Supervisory Board





Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR CORPORATE AND INSTITUTIONAL CLIENTS

Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).

The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.

Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended), citizen/resident of Australia, Canada, Great Britain and Japan. For this reason, the distribution or redistribution of the information, materials and products into United States, Australia, Canada, Great Britain and Japan or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited.

The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.

The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.

By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.
(iV) It is no consumer.